
SK Bioscience Co. has inaugurated its new Global R&PD Center in Songdo, Incheon, investing 377.2 billion won ($284 million) to enhance its premium vaccine portfolio and expand global development capabilities.
Viral immunologist taps ‘incredible potential’ of immune system
Viral immunologist Paul Thomas, PhD, is working to turn the “incredible potential” of the immune system into real-life…
#NewsBeep #News #Headlines #BezosFamily #Cancerimmunotherapy #computationalbiology #geneticallyengineeredtcells #Immunologyvaccinedevelopment #influenza #Latvia #LV #PaulThomas #Tcell #TCR #VaccineandInfectiousDisease #vaccinedevelopment
https://www.newsbeep.com/231156/
New Vaccine Shows Promise Against Deadly Elephant Virus Causing High Juvenile Mortality
Researchers have developed a promising new vaccine to protect young Asian elephants from elephant endotheliotropic herpesvirus (EEHV), a virus that causes severe, often fatal hemorrhagic disease. This virus has caused over 100 deaths in captive young elephants worldwide, including seven at Chester Z... [More info]
Bill Gates, during a meeting with President Lee Jae-myung in Seoul, praised South Korea's rapid advances in bioscience and highlighted the nation's key role in global vaccine and health innovation.
Revolutionizing vaccine development! MRNA vaccines offer speed, purity & potency. By delivering the genetic code directly, they induce an immune response quickly and efficiently. Say goodbye to contaminants and hello to effective protection!
Watch the full episode at http://bit.ly/3UOKGYR